First Discovery of the Dual-Functional Inhibitor Targeting VEGFR/PDGFR/CA II for the Treatment of Neovascular Glaucoma
Authors
- Zhenli Li (ORCID: https://orcid.org/0000-0002-3682-164X)
- Jingkai Gu (ORCID: https://orcid.org/0000-0002-4731-6649)
- Jiarao Wang
- Maosheng Cheng (ORCID: https://orcid.org/0000-0001-9073-4806)
- Xudong Wang (ORCID: https://orcid.org/0009-0005-6369-1317)
- Yang Liu (ORCID: https://orcid.org/0000-0002-9284-1944)
- Huali Yang (ORCID: https://orcid.org/0000-0002-0557-9870)
- Jiachong Chi
- Yulong Cheng
- Xiaomeng Xiu
- Fangbo Deng
Institutions
- Shenyang Pharmaceutical University (CN)
- Center for Drug Evaluation and Research (US)
- Jilin University (CN)
- Jilin Medical University (CN)
Funders
- Department of Education of Liaoning Province